Related Experiment Video
Updated: May 18, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells
Jing-Yi Yuan1, Li-Ying Liu, Pei Wang
1Department of Genetics and Molecular Biology, Medical School of Xi'an Jiaotong University/Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Shaanxi 710061.
Abstract:
The genesis and progression of cervical cancer involve the mutation or deviant expression of numerous genes, including the activation of oncogenes (Ha-ras, C-myc, C-erbB2 and Bcl-2) and inactivation of tumor-suppressor genes (p53 and Rb). Previous studies showed that small-interfering RNAs (siRNAs) targeting the MAPK p42 gene partly inhibit proliferation and increase apoptosis in human cervical carcinoma HeLa cells. Results of a microarray analysis showed that MAPK p42 siRNA inhibited cell growth through the regulation of cell cycle control and apoptosis and induced interferon-like response in HeLa cells. In order to confirm the dual effects of MAPK p42 siRNA, we compared the roles of siRNA and U0126, an inhibitor of MAPK p42, in HeLa cells. Short 21-mer double-stranded/siRNAs were synthesized to target MAPK p42 mRNA in HeLa cells. The siRNAs were transfected into HeLa cells using Lipofectamine. The cells were treated with siRNA or U0126 at different concentrations for a period of 48 h. The biological effect of siRNA and U0126 on HeLa cells was measured by MTT and flow cytometry. MAPK1, NUP188, P38, STAT1, STAT2, PML and OAS1 were analyzed by real-time quantitative PCR. HeLa cell growth was inhibited by siRNA or U0126, and the effect of siRNA inhibition was greater than that of U0126. Cell cycle phases were different for siRNA or U0126, but HeLa cell growth was arrested at the S phase by siRNA and at G1 phase by U0126. A down-regulation in MAPK p42 expression by siRNA and up-regulation by U0126 were noted. The results of real-time quantitative PCR showed that P38 was up-regulated and NUP188 was down-regulated by siRNA in comparison with the control groups, and the results were consistent with those of U0126. Expression levels of STAT1, STAT2, PML and OAS1 induced by siRNA differed from those induced by U0126. siRNA-mediated silencing and deactivation induced by U0126 in MAPK p42 led to growth inhibition in the HeLa cells. The effects of siRNA on HeLa cell growth were different from those of U0126. Dual effects of MAPK p42 siRNA-2 on HeLa cell growth were noted: one consisted of a specific effect induced by siRNA-mediated p42 MAPK silencing and the other exhibited a non-specific interferon-like response.
Insights
Small-interfering RNAs (siRNAs) targeting MAPK p42 inhibit cervical cancer cell growth more effectively than U0126. MAPK p42 siRNA induces cell cycle arrest at S phase and an interferon-like response, unlike U0126.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Cervical cancer progression involves oncogene activation and tumor suppressor gene inactivation.
- Small-interfering RNAs (siRNAs) targeting MAPK p42 have shown potential in inhibiting HeLa cell proliferation and inducing apoptosis.
Purpose of the Study:
- To confirm the dual effects of MAPK p42 siRNA and compare its role with U0126, a MAPK p42 inhibitor, in HeLa cells.
- To investigate the specific mechanisms of growth inhibition and cell cycle regulation induced by MAPK p42 siRNA.
Main Methods:
- siRNAs targeting MAPK p42 mRNA were synthesized and transfected into HeLa cells.
- Cells were treated with siRNA or U0126, and biological effects were measured using MTT and flow cytometry.
- Gene expression analysis (MAPK1, NUP188, P38, STAT1, STAT2, PML, OAS1) was performed using real-time quantitative PCR.
Main Results:
- Both siRNA and U0126 inhibited HeLa cell growth, with siRNA showing a greater effect.
- siRNA induced S phase arrest, while U0126 induced G1 phase arrest.
- siRNA-mediated MAPK p42 silencing resulted in distinct gene expression changes compared to U0126 treatment, including P38 upregulation and NUP188 downregulation, and an interferon-like response.
Conclusions:
- siRNA-mediated silencing of MAPK p42 effectively inhibits HeLa cell growth, exhibiting dual effects including specific gene silencing and a non-specific interferon-like response.
- The distinct cell cycle arrest phases and gene expression profiles highlight the differential mechanisms of action between siRNA and U0126.
- MAPK p42 siRNA represents a potent therapeutic strategy for cervical cancer, with effects differing from chemical inhibitors.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Abnormal Proliferation
Experimental RNAi
MicroRNAs
MicroRNAs

